Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Findit who wrote (15409)	11/14/2003 3:42:41 PM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

Bingo, ARIA--another new 52w high, target is still $11.00 Not bad for a 1.50 bottom fish.. Message 18875867 CAMBRIDGE, Mass., Nov 14, 2003 (BUSINESS WIRE) -- ARIAD Pharmaceuticals, Inc. (ARIA, Trade) today announced that the Company will be included in the NASDAQ Biotechnology Index(R) (NBI) effective with the market open on Monday, November 24, 2003. Index eligibility criteria include market value, average daily share volume and "seasoning" as a public company. With the new additions, there will be 130 companies included in the Index. The NBI is the basis for the iShares Nasdaq Biotechnology Index(SM) Fund (NBI) managed by Barclays Global Fund Advisors. In addition, options based on both the NBI and IBB trade on various exchanges. I wish XTRN could get some of that there "seasoning" My only held loser for this whole year... I think XTRN managment seasoned me!!